Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate – activated protein kinase in subjects with hypercholesterolemia: The results of a double-blind, parallel group, multicenter, placebo controlled trial - Ballantyne, C M; Davidson, M H; Macdougall, D E (J Am Coll Cardiol, 2013)
10.1016/j.jacc.2013.05.050